Wolzt, Michael <br/><br/>
Effects of the oral direct thrombin inhibitor ximelagatran on p-selectin expression and thrombin generation in atrial fibrillation.  [electronic resource] 

 -  Pathophysiology of haemostasis and thrombosis   
 - 68-74 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1424-8832 
<br/><br/><label>Standard No.: </label>10.1159/000073849  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Atrial Fibrillation--blood<br/>Azetidines--administration & dosage<br/>Benzylamines<br/>Blood Coagulation Tests<br/>Case-Control Studies<br/>Female<br/>Glycine--analogs & derivatives<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>P-Selectin--biosynthesis<br/>Platelet Activation--drug effects<br/>Thrombin--antagonists & inhibitors<br/>Thrombosis--drug therapy